Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 1423053 MIAMI, FL
Back to ARCT Full portfolio

Position in ARCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$275,156
+$6,639 QoQ
Shares Held
40,946
+17.7% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 133 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARCT Over Time

Shares Held

Position Value (USD)

Derivatives in ARCT

reported options exposure · as of Mar 31, 2026
CallValue
$152,856
CallShares
19,800
PutValue
$753,472
PutShares
97,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ARCT ranks #299 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ARCT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $275,156 40,946
2026-03-31 $152,856 19,800
2026-03-31 $753,472 97,600
2026-03-31 $268,517 34,782
2025-12-31 $739,891 120,700
2025-12-31 $528,406 86,200
2025-09-30 $409,146 22,200
2025-09-30 $938,087 50,900
2025-09-30 $776,271 42,120
2025-06-30 $464,457 35,700
2025-06-30 $373,126 28,680
2025-06-30 $879,476 67,600
2025-03-31 $228,744 21,600
2025-03-31 $67,172 6,343
2025-03-31 $562,329 53,100
2024-12-31 $232,098 13,677
2024-12-31 $875,652 51,600
2024-12-31 $449,705 26,500
2024-09-30 $1,760,571 75,854
2024-09-30 $830,918 35,800
2024-09-30 $317,977 13,700
2024-06-30 $526,738 21,632
2024-06-30 $1,051,920 43,200
2024-06-30 $323,855 13,300
2024-03-31 $361,339 10,700
2024-03-31 $715,924 21,200
2024-03-31 $5,642,764 167,094
2023-12-31 $725,190 23,000
2023-12-31 $11,571 367
2023-12-31 $1,150,845 36,500
2023-09-30 $3,778,154 147,873
2023-09-30 $357,700 14,000
2023-09-30 $1,042,440 40,800
2023-06-30 $3,496,406 121,911
2023-06-30 $1,129,992 39,400
2023-06-30 $760,020 26,500
2023-03-31 $7,545,491 314,789
2023-03-31 $462,621 19,300
2023-03-31 $894,081 37,300
2022-12-31 $264,576 15,600
2022-12-31 $2,267,552 133,700
2022-12-31 $5,144,068 303,306
2022-09-30 $2,821,772 190,403
2022-09-30 $1,527,942 103,100
2022-06-30 $1,408,730 89,500
2022-06-30 $262,858 16,700
2022-06-30 $1,000,055 63,536
2022-03-31 $2,632,184 97,633
2022-03-31 $819,584 30,400
2022-03-31 $2,458,752 91,200

Report a Problem

Category
Description
Email (optional, for follow-up)